Ferric Citrate is available as DC Grade and has better phosphate binding capacity. It treats iron deficiency anemia as well. Ferric Citrate tablets are also used to prevent fatigue and promoting good skin tone. Only oral medication available which replenishes iron & maintain serum phosphorous level.
Molecular Formula – C6H6FeO7
Molecular Weight – 245.95 gm/mol
CAS No – 23383-11-1
Shelf Life – 36 months
HSN Code –
Packing Size –
Storage Condition – Keep Well Closed, protected against light, dry and at room temperature
Additional Info –
| Sl. No. | PARAMETER | SPECIFICATION |
| 1. | Description | Brown hygroscopic granules with powder. |
| 2. | pH (of 5% w/v solution) | 6.0-8.0 |
| 3. | Loss on Drying (at 105°C for 4hrs) | NMT 10.0% w/w. |
| 4. | Iron Content (On Dried Basis) | 18.0% w/w-22.0%w/w |
| 5. | Bulk Density
· Untapped Density · Tapped Density |
NLT 0.60gm/cc. NLT 0.70gm/cc. |
| 6. | Particle Size
· Through 18# · Through 80# |
Report Value. Report Value. |
| 7. | Compressibility Index | NMT 20.0% |
| 8. | Total Microbial Count | Less than 1000cfu/gm. |
| 9. | Total Yeasts & Moulds Count | Less than 100cfu/gm. |
| 10. | E.coli | Absent. |
| Category | Description |
|---|---|
| Pharmaceutical Drug | Only Pharmaceutical usage. |
Background: Most dialysis patients require phosphate binders to control hyperphosphatemia. Ferric citrate has been tested in phase 2 trials as a phosphate binder. This trial was designed as a dose-response and efficacy trial. Study design: Prospective, phase 3, multicenter, open-label,...
Read moreIron deficiency, anemia, hyperphosphatemia, and increased fibroblast growth factor 23 (FGF23) are common and interrelated complications of chronic kidney disease (CKD) that are linked to CKD progression, cardiovascular disease and death. Ferric citrate is an oral phosphate binder that decreases...
Read more